Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Contact dermatitis".)
International
●Expert consensus on ceramides containing skincare in newborns and infants and potential mitigation of atopic dermatitis (2022)
●International Society of Atopic Dermatitis (ISAD)/Oriented Patient‐Education Network in Dermatology (OPENED): A position paper on the management of itch and pain in atopic dermatitis (2020)
●International Eczema Council (IEC): Consensus statement on the use of systemic corticosteroids for atopic dermatitis (2018)
Canada
●Approach to the assessment and management of pediatric patients with atopic dermatitis – A consensus document (2019)
•Section I – Overview of pediatric atopic dermatitis
•Section II – Comorbid disease in pediatric atopic dermatitis
•Section III – Treatment options for pediatric atopic dermatitis
•Section IV – Consensus statements on the assessment and management of pediatric atopic dermatitis
●Canadian Society of Allergy and Clinical Immunology (CSACI): Position statement – Safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults (2013)
United States
●American Academy of Dermatology (AAD): Guidelines – Awareness of comorbidities associated with atopic dermatitis in adults (2022)
●Choosing Wisely: Avoid the use of systemic (oral or injected) corticosteroids in most cases of atopic dermatitis (2021)
●Choosing Wisely: Don't routinely use oral antibiotics for treatment of atopic dermatitis (2013, updated 2021)
●Choosing Wisely: Don't use skin prick tests or blood tests such as the radioallergosorbent test (RAST) for the routine evaluation of eczema (2021)
●Choosing Wisely: Don't use systemic (oral or injected) corticosteroids as a long-term treatment for dermatitis (2015, updated 2021)
●AAD: Guidelines of care for the management of atopic dermatitis (2014)
•Diagnosis and assessment of atopic dermatitis
•Management and treatment of atopic dermatitis with topical therapies
•Management and treatment with phototherapy and systemic agents
•Prevention of disease flares and use of adjunctive therapies and approaches
●American Academy of Pediatrics (AAP): Clinical report on atopic dermatitis – Skin-directed management (2014)
●American Academy of Allergy, Asthma, and Immunology (AAAAI), American College of Allergy, Asthma, and Immunology (ACAAI), and Joint Council of Allergy, Asthma, and Immunology (JCAAI): Practice parameter on atopic dermatitis, 2012 update (published 2013)
Europe
●Centre for Guideline Development (EuroGuiDerm) and European Dermatology Forum (EDF): Guideline on atopic eczema (2022)
●European Task Force on Atopic Dermatitis (ETFAD)/European Academy of Dermatology and Venereology (EADV): Position paper on diagnosis and treatment of atopic dermatitis in adults and children (2020)
●ETFAD: Position paper – Treatment of parental atopic dermatitis during preconception, pregnancy and lactation period (2019)
●EDF, EADV, European Academy of Allergy and Clinical Immunology (EAACI), ETFAD, European Federation of Allergy and Airways Diseases Patients' Associations (EFA), European Society for Dermatology and Psychiatry (ESDaP), European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN), and European Union of Medical Specialists (UEMS): Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children – Part I (2018)
●EDF, EADV, EAACI, ETFAD, EFA, ESDaP, ESPD, GA2LEN, and UEMS: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children – Part II (2018)
●EAACI and GA2LEN: Position paper on eczematous reactions to food in atopic eczema (2007)
United Kingdom
●Primary Care Dermatology Society (PCDS): Eczema – Atopic eczema (2012, updated 2022)
●National Institute for Health and Care Excellence (NICE): Clinical guideline on atopic eczema in under 12s – Diagnosis and management (2007, updated 2021)
●NICE: Guideline on secondary bacterial infection of eczema and other common skin conditions – Antimicrobial prescribing (2021)
●NICE: Quality standard on atopic eczema in under 12s (2013)
●Royal College of Paediatrics and Child Health (RCPCH): Allergy care pathways for children – Eczema (2011)
India
●Guidelines on management of atopic dermatitis in India – An evidence-based review and an expert consensus (2019)
Australia–New Zealand
●Australasian College of Dermatologists (ACD): Consensus statement on topical corticosteroids in paediatric eczema (2017, updated 2022)
●ACD: Consensus statement on management of atopic dermatitis in adults (2021)
●Choosing Wisely Australia: Do not recommend that patients take systemic non-sedating antihistamine for itchy rashes, i.e. eczema, psoriasis. Non-sedating antihistamines can be prescribed for urticaria according to the ASCIA guidelines (2021)
●Atopic dermatitis in adults – An Australian management consensus (2019)
Japan
●[In Japanese] Japanese Dermatological Association (JDA) and Japanese Society of Allergology (JSA): Atopic dermatitis clinical practice guideline (2021)
●[In English] JSA: Consensus statements on pediatric atopic dermatitis from dermatology and pediatrics practitioners in Japan – Goals of treatment and topical therapy (2020)
●[In English] JSA and JDA: Japanese guidelines for atopic dermatitis (2020)
●[In English] Consensus guidelines for the management of atopic dermatitis – An Asia-Pacific perspective (2013)
